Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on Thursday, April 3rd, IPO Scoop reports. The company will be issuing 2,700,000 shares at $7.50-$8.50 per share.

Image Source: Freepik Astrology exposes profound spiritual and mystical aspects in addition to personalities and relationships. Some signs of the zodiac are inherently more sensitive to ...

Wolf and Dr. Rubinek team at Tel Aviv University and Sourasky Medical Center REHOVOT, Israel, April 16, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ ...

Blast Processing Mystical Fighter – Sega Genesis Posted: April 9, 2025 | Last updated: April 9, 2025 Welcome to The Blast Processor! 🎮🔥 If you're a fan of retro gaming, epic gameplay, and ...

CitiCorp Services India Pvt Ltd has leased commercial office space in Panchshil Business Hub, at Kharadi, in Pune, spread across 10 floors In one of the largest commercial office space rental ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

U.K.-based Epsilogen has bought Boston biotech TigaTx with the aim of creating “the world’s leading pan-isotype cancer antibody company.” Both companies are focused on immunoglobulin ...

The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating funding for an Atlanta biotech’s lead COVID-19 vaccine program that’s ...

A "magic" island on the Northumberland coast is one of the must-visit destinations for 2025 after being named among the "most beautiful" places to see in England. While there are arguably plenty ...

Roivant Sciences Ltd. (NASDAQ:ROIV) is a biopharmaceutical company that develops transformative medicines, ranking it on our list of the best mid cap biotech stocks to invest in. Its product ...

Legend Biotech has no tariff exposure and manufactures Carvykti entirely in the U.S. for both U.S. and EU markets. HC Wainwright maintains a $75 target, citing Carvykti’s strong efficacy and ...